Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenica Ronchetti

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Cells|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple MyelomaMaría Labrador, Sara Cozzubbo, Mariangela Porro, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Haematologica|January 7, 2017
<i>IL21R</i> expressing CD14<sup>+</sup>CD16<sup>+</sup> monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.
Haematologica|July 13, 2023
<i>DIS3</i> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplificationVanessa K Favasuli, Domenica Ronchetti, Ilaria Silvestris, et al.
Leukemia|August 21, 2019
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myelomaElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Experimental Hematology & Oncology|September 12, 2022
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström MacroglobulinemiaEugenio Morelli, Zachary R Hunter, Mariateresa Fulciniti, et al.
Blood|March 20, 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changesMarta Lionetti, Margherita Scopetti, Antonio Matera, et al.
Blood Advances|June 3, 2024
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysisFrancesca Lazzaroni, Antonio Matera, Alessio Marella, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Haematologica|July 11, 2024
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myelomaNoemi Puccio, Gloria Manzotti, Elisabetta Mereu, et al.
Cells|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple MyelomaMaría Labrador, Sara Cozzubbo, Mariangela Porro, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Haematologica|January 7, 2017
<i>IL21R</i> expressing CD14<sup>+</sup>CD16<sup>+</sup> monocytes expand in multiple myeloma patients leading to increased osteoclastsMarina Bolzoni, Domenica Ronchetti, Paola Storti, et al.
Haematologica|July 13, 2023
<i>DIS3</i> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplificationVanessa K Favasuli, Domenica Ronchetti, Ilaria Silvestris, et al.
Leukemia|August 21, 2019
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myelomaElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Experimental Hematology & Oncology|September 12, 2022
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström MacroglobulinemiaEugenio Morelli, Zachary R Hunter, Mariateresa Fulciniti, et al.
Blood|March 20, 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changesMarta Lionetti, Margherita Scopetti, Antonio Matera, et al.
Blood Advances|June 3, 2024
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysisFrancesca Lazzaroni, Antonio Matera, Alessio Marella, et al.
Pageof 5